Epilepsy Society
Epilepsy Society is a UK registered charity (No. 206186) that delivers specialist epilepsy medical services, research including a national genomics programme, residential and supported living care, advocacy, and a national helpline to people with epilepsy, their families, and healthcare professionals.
- Company typePrivate
- Founded1892
- HeadquartersChalfont Saint Peter, United Kingdom
- Headcount251–500
- GTM typeB2C
- OfferingServices
What Epilepsy Society does
Epilepsy Society is a UK registered charity (Charity No. 206186) founded in 1892 and headquartered at the Chalfont Centre in Chalfont St Peter, Buckinghamshire, with a workforce of 251–500 staff. It operates across four functional pillars: specialist medical services (MRI scanning, EEG recording including video telemetry, sleep-deprived EEG, ambulatory EEG, and Therapeutic Drug Monitoring), a research programme spanning genomics, neuroimaging, neuropathology, and neuropsychology — including the UK's only specialist epilepsy genomics clinic running whole genome sequencing — care services (residential care homes, STEPS supported living, overnight respite), and an advocacy and information function delivered via a confidential helpline, training programmes for families and professionals, and a global-facing website (epilepsysociety.org.uk). The proprietary EASEE device (Epicranial Application of Stimulation Electrodes for Epilepsy) is offered on the NHS for people with drug-resistant focal seizures.
The organisation funds its operations through a diversified income mix including individual donations, legacies and gifts in Wills, membership fees, fundraising events (walks, treks, runs, skydiving, overseas challenges), corporate partnerships, and shop proceeds; services are delivered free at the point of use consistent with its charitable mission. It serves a UK population of more than 600,000 people with epilepsy and addresses a clinical burden of 79 new diagnoses per day and roughly 1,200 epilepsy-related deaths per year. Customer-facing segments include people with epilepsy (and subgroups such as children, women, and those with learning disabilities), families and carers, healthcare professionals, and people requiring residential or supported living care. The organisation is governed by a Board of Trustees with Clare Pelham as Chief Executive, and there are no subsidiaries, parent entities, or external investors.
Go-to-market is multi-channel: direct in-person service delivery at the Chalfont Centre and care homes, plus a distributed digital and community-channel infrastructure (helpline across phone/email/webchat, a comprehensive A–Z website, social media presence on Facebook, X, YouTube, Instagram and LinkedIn, monthly e-newsletters, and events-based fundraising). The organisation markets itself as the only UK charity integrating research, advocacy, and care under a single brand, and operates Cyber Essentials and Cyber Essentials Plus certifications alongside its charity registration.
Epilepsy Society firmographics
Firmographics- Name
- Epilepsy Society
- Legal name
- Epilepsy Society
- Website
- https://epilepsysociety.org.uk
- Company type
- Private
- Founded year
- 1892
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Epilepsy Society is a UK registered charity (No. 206186) that delivers specialist epilepsy medical services, research including a national genomics programme, residential and supported living care, advocacy, and a national helpline to people with epilepsy, their families, and healthcare professionals.
- Ownership category
- akta.pro rank
Epilepsy Society industry classification
Industry- Product category
- Epilepsy Healthcare and Research Services
- NAICS
- Social Assistance (624), Residential Intellectual and Developmental Disability Facilities (62321)
- SIC
- Services-Health Services (8000), Services-Skilled Nursing Care Facilities (8051)
- akta.pro primary industry
- Epilepsy & Seizure Disorders (HLAKAIAB)
- akta.pro secondary industry
- Neurogenetics & Rare Neurologic Diseases (HLAKAIAO)
Keywords
Where Epilepsy Society is headquartered
LocationHeadquarters
- HQ city
- Chalfont Saint Peter
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
Epilepsy Society business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Others
Distribution channels6 records
Marketing channels8 records
Epilepsy Society product offering
Product offeringCore offering
Epilepsy Society is a UK charity that delivers specialist epilepsy medical services (MRI, EEG, Therapeutic Drug Monitoring), world-leading genomics research, residential and supported living care, training programmes, advocacy campaigns, and a confidential helpline to people affected by epilepsy.
Product overview
Epilepsy Society operates as a UK charity offering a unified portfolio of services centred on epilepsy care, research, and advocacy. The core offerings include medical diagnostic services (MRI, EEG, Therapeutic Drug Monitoring), research programmes (genomics, neuroimaging, neuropathology), and care services (residential homes, STEPS supported living, respite care). These are complemented by a confidential helpline, epilepsy training programmes for professionals and families, and various advocacy campaigns. The services work together to provide end-to-end support from diagnosis through ongoing care and community support.
Differentiator
Problem solved
Functional benefit
Brands
- STEPS - Supported living: Supported living services for people with epilepsy
- The Phoenix Cafe
- Genomics Research Programme
Products and services
- Medical Services Clinical services delivered at the Chalfont Centre for Epilepsy, including MRI scanning, EEG testing, video telemetry, sleep-deprived and ambulatory EEG, day case admissions, and specialist outpatient appointments for people with epilepsy.
- Therapeutic Drug Monitoring (TDM) Clinical chemistry service measuring anti-seizure medication levels in patients through blood or saliva samples to optimise epilepsy treatment.
- Research Services Research programme encompassing genomics, neuroimaging, neuropathology, and neuropsychology to understand and treat epilepsy.
- Genomics Research Programme World-leading genomics research to understand the genetic architecture of each individual's epilepsy, enabling personalised treatment approaches through whole genome sequencing.
- Care Services Range of care options including residential care homes, STEPS supported living, and overnight respite care tailored to individual needs of people with epilepsy.
- STEPS Supported Living Supported living services for people with epilepsy to maximise independence and life potential.
- Epilepsy Helpline Confidential helpline providing emotional support and information for anyone affected by epilepsy, available by phone, email, or webchat.
- Epilepsy Training Training programmes including family and friends courses and professional training for those working with people affected by epilepsy.
- Advocacy Campaigns Advocacy campaigns including FixIt4Free for free dental care, #ZachsLaw for online safety, Safe Mum Safe Baby, and medication shortage advocacy to push epilepsy up the political agenda.
Quantifiable outcome
- Up to 70% of people with epilepsy could have their seizures controlled with the right medication
- +2 more outcomes
Companies that use Epilepsy Society
Customer profileSegments6 records
Ideal customer profiles4 records
Epilepsy Society technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Epilepsy Society partnerships and signals
Strategic signalScale indicators5 records
Recent moves5 records
Expansion highlights4 records
Epilepsy Society competitors and assessment
Company assessmentDirect peers
- Epilepsy Foundation: Major US-based epilepsy charity offering research funding, advocacy, and patient services. Comparable integrated model of research, advocacy, and direct services to people with epilepsy, albeit at much larger scale.
- Epilepsy Action: UK charity providing information, support, and advocacy for people with epilepsy. Operates a helpline and campaigns similar to Epilepsy Society, making it the closest direct peer in the UK epilepsy charity space.
- Parkinson's UK: Major UK charity combining research funding, information and support services, and advocacy for a single neurological condition. Highly comparable charity operating model and structure to Epilepsy Society.
- Epilepsy Research UK: UK charity dedicated to funding and driving epilepsy research. Closely comparable research mission and overlapping donor base with Epilepsy Society's research programme.
- SUDEP Action: UK charity focused on Sudden Unexpected Death in Epilepsy, combining research funding, awareness, and bereavement support. Operates in the same UK epilepsy charity ecosystem with overlapping constituencies.
- Alzheimer's Research UK: UK charity funding research and providing information on a neurological condition, with comparable research-driven mission and fundraising model. Similar size and operational profile to Epilepsy Society within the neurological charity space.
- Young Epilepsy: UK charity focused on children and young people with epilepsy, combining specialist residential education, medical services, and research. Comparable model of combining care, research, and support services in the epilepsy space.
Broad incumbents
- British Heart Foundation: Large UK health charity combining research funding, patient information, and retail-based fundraising. Comparable charity operating model at much larger scale; useful benchmark for charity growth and fundraising infrastructure.
- Macmillan Cancer Support: Major UK charity combining research, support services, and advocacy for people affected by a specific condition. Highly comparable integrated charity model with helpline, information, and campaigning functions.
- International League Against Epilepsy (ILAE): Global professional organisation driving epilepsy research, education, and clinical guidelines. Comparable in research focus and influence on epilepsy care standards, though operates internationally rather than as a UK service provider.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Epilepsy Society social profiles
Digital presenceEpilepsy Society compliance and trust
Trust signalCompliance3 records
Epilepsy Society financial estimates
Financial estimateRevenue estimate
Valuation estimate
Epilepsy Society leadership team
Management profileNumber of profiles
Profiles1 record
Epilepsy Society funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Epilepsy Society M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Epilepsy Society
What does Epilepsy Society do?
Epilepsy Society is a UK charity that delivers specialist epilepsy medical services (MRI, EEG, Therapeutic Drug Monitoring), world-leading genomics research, residential and supported living care, training programmes, advocacy campaigns, and a confidential helpline to people affected by epilepsy.
Is Epilepsy Society a public or private company?
Epilepsy Society is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Epilepsy Society founded?
Epilepsy Society was founded in 1892. It employs 251 to 500 people.
Where is Epilepsy Society based?
Epilepsy Society is headquartered in Chalfont Saint Peter, United Kingdom, in the Europe region.
Who are Epilepsy Society's main competitors?
Direct peers on record are Epilepsy Foundation, Epilepsy Action, Parkinson's UK, Epilepsy Research UK, SUDEP Action, Alzheimer's Research UK and Young Epilepsy. Broad incumbents are British Heart Foundation, Macmillan Cancer Support and International League Against Epilepsy (ILAE).
Does Epilepsy Society have an API?
No public API is recorded for Epilepsy Society.
What industry is Epilepsy Society in?
Epilepsy Society's product category is Epilepsy Healthcare and Research Services. Its primary akta.pro industry code is HLAKAIAB, Epilepsy & Seizure Disorders, with a secondary code of HLAKAIAO, Neurogenetics & Rare Neurologic Diseases. Its NAICS code is 624 and its SIC code is 8000.